- United Kingdom Cell and Gene Therapy Manufacturing QC Market, By Therapy Type (2021-2033)
- Cell Therapy
- CAR-T
- CAR-NK
- B-Cell
- Others
- Gene Therapy
- Viral
- Non-viral
- United Kingdom Cell and Gene Therapy Manufacturing QC Market, By Scale (2021-2033)
- Pre-commercial/ R&D Manufacturing
- Commercial Scale Manufacturing
- United Kingdom Cell and Gene Therapy Manufacturing QC Market, By Mode (2021-2033)
- Contract Manufacturing
- In-house Manufacturing
- United Kingdom Cell and Gene Therapy Manufacturing QC Market, By Workflow (2021-2033)
- Cell Processing
- Cell Banking
- Fill & Finish Operations
- Raw Material Testing
- Vector Production
- Other Workflows
- United Kingdom Cell and Gene Therapy Manufacturing QC Market, By Process (2021-2033)
- Upstream Processes
- Downstream Processes
- United Kingdom Cell and Gene Therapy Manufacturing QC Market, By End-User (2021-2033)
- Pharmaceutical Companies
- Biopharmaceutical / Biotechnological Companies
- Contract Manufacturing Organizations
- United Kingdom Cell and Gene Therapy Manufacturing QC Market, By Technology Type (2021-2033)
- Fluorescence-Activated Cell Sorting (FACS)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Chromatography
- Next-Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Others